Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 332

1.

Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer.

Kong AL, Tereffe W, Hunt KK, Yi M, Kang T, Weatherspoon K, Mittendorf EA, Bedrosian I, Hwang RF, Babiera GV, Buchholz TA, Meric-Bernstam F.

Cancer. 2012 Dec 15;118(24):6287-96. doi: 10.1002/cncr.27564. Epub 2012 May 30.

2.

The relation of visualization of internal mammary lymph nodes on lymphoscintigraphy to axillary lymph node metastases in breast cancer.

Kim H, Shin MJ, Kim SJ, Kim IJ, Park I.

Lymphat Res Biol. 2014 Dec;12(4):295-300. doi: 10.1089/lrb.2013.0039.

PMID:
25144255
3.

Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer.

Yao MS, Kurland BF, Smith AH, Schubert EK, Dunnwald LK, Byrd DR, Mankoff DA.

Ann Surg Oncol. 2007 Oct;14(10):2985-93. Epub 2007 Jun 13.

PMID:
17564747
4.

Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?

Brenot-Rossi I, Houvenaeghel G, Jacquemier J, Bardou VJ, Martino M, Hassan-Sebbag N, Pasquier J.

J Nucl Med. 2003 Aug;44(8):1232-7.

5.

Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of Oncology.

Intra M, Viale G, Vila J, Grana CM, Toesca A, Gentilini O, Galimberti V, Veronesi P, Luini A, Rotmensz N, Bagnardi V, Mattar D, Colleoni M.

Ann Surg Oncol. 2015 Jul;22(7):2372-7. doi: 10.1245/s10434-014-4282-5. Epub 2014 Dec 17.

PMID:
25515197
6.

Prognostic Significance of Tumor-Positive Internal Mammary Sentinel Lymph Nodes in Breast Cancer: A Multicenter Cohort Study.

Madsen EV, Aalders KC, van der Heiden-van der Loo M, Gobardhan PD, van Oort PM, van der Ent FW, Rutgers EJ, Vald├ęs Olmes RA, Elias SG, van Dalen T.

Ann Surg Oncol. 2015 Dec;22(13):4254-62. doi: 10.1245/s10434-015-4535-y. Epub 2015 Mar 26.

PMID:
25808100
7.

Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer.

Chagpar AB, Kehdy F, Scoggins CR, Martin RC 2nd, Carlson DJ, Laidley AL, El-Eid SE, McGlothin TQ, Noyes RD, Ley PB, Tuttle TM, McMasters KM.

Am J Surg. 2005 Oct;190(4):557-62.

PMID:
16164919
8.

Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer.

Kawase K, Gayed IW, Hunt KK, Kuerer HM, Akins J, Yi M, Grimes L, Babiera GV, Ross MI, Feig BW, Ames FC, Singletary SE, Buchholz TA, Symmans WF, Meric-Bernstam F.

J Am Coll Surg. 2006 Jul;203(1):64-72. Epub 2006 May 26.

PMID:
16798488
9.

Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients.

Heuts EM, van der Ent FW, von Meyenfeldt MF, Voogd AC.

Eur J Surg Oncol. 2009 Mar;35(3):252-7. doi: 10.1016/j.ejso.2008.06.1493. Epub 2008 Aug 5.

PMID:
18684584
10.
11.

Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy.

Haigh PI, Hansen NM, Giuliano AE, Edwards GK, Ye W, Glass EC.

J Nucl Med. 2000 Oct;41(10):1682-8.

13.

The role of lymphoscintigraphy in the management of the patient with breast cancer.

Dupont EL, Kamath VJ, Ramnath EM, Shivers SC, Cox C, Berman C, Leight GS Jr, Ross MI, Blumencranz P, Reintgen DS; DOD Breast Lymphatic Mapping Trial Investigators.

Ann Surg Oncol. 2001 May;8(4):354-60.

PMID:
11352310
14.

Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.

Agresti R, Crippa F, Sandri M, Martelli G, Tagliabue E, Alessi A, Pellitteri C, Maccauro M, Maugeri I, Barbara P, Rampa M, Moscaroli A, Ferraris C, Carcangiu ML, Bianchi G, Greco M, Bombardieri E.

Breast. 2014 Aug;23(4):334-40. doi: 10.1016/j.breast.2014.01.001. Epub 2014 Jan 31.

PMID:
24485802
15.

Accurate staging with internal mammary chain sentinel node biopsy for breast cancer.

Gnerlich JL, Barreto-Andrade JC, Czechura T, John JR, Turk MA, Kennedy TJ, Winchester DJ.

Ann Surg Oncol. 2014 Feb;21(2):368-74. doi: 10.1245/s10434-013-3263-4. Epub 2013 Sep 18.

PMID:
24046119
16.

Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures.

Tokmak H, Kaban K, Muslumanoglu M, Demirel M, Aktan S.

World J Surg Oncol. 2014 Jul 12;12:205. doi: 10.1186/1477-7819-12-205.

17.

Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients.

Caudle AS, Yi M, Hoffman KE, Mittendorf EA, Babiera GV, Hwang RF, Meric-Bernstam F, Sahin AA, Hunt KK.

Ann Surg Oncol. 2014 Jan;21(1):60-5. doi: 10.1245/s10434-013-3276-z. Epub 2013 Sep 18.

PMID:
24046126
18.

Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.

Lawson LL, Sandler M, Martin W, Beauchamp RD, Kelley MC.

Am Surg. 2004 Dec;70(12):1050-5; discussion 1055-6.

PMID:
15663043
19.

Disease recurrence in sentinel node-positive breast cancer patients forgoing axillary lymph node dissection.

Cyr A, Gao F, Gillanders WE, Aft RL, Eberlein TJ, Margenthaler JA.

Ann Surg Oncol. 2012 Oct;19(10):3185-91. doi: 10.1245/s10434-012-2547-4. Epub 2012 Aug 14.

Supplemental Content

Support Center